We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CYH Sustains Its Divestiture Spree Through Alabama Facility Sale
Read MoreHide Full Article
Key Takeaways
CYH completed the $459M sale of 180-bed Crestwood Medical Center and related outpatient assets.
CYH signed the Crestwood deal in January and closed it within the expected second-quarter 2026 window.
CYH's divestitures unlock capital and are likely to cut debt and fund capital expenditures.
Community Health Systems, Inc. (CYH - Free Report) recently completed the sale of Alabama-based Crestwood Medical Center to Huntsville Hospital Health System for $459 million, prior to certain transaction-related costs. A subsidiary of the company sold all of the assets of Crestwood Medical Center, including its affiliated outpatient facilities and physician practices.
The agreement to sell the 180-bed facility was inked this January and was likely to be completed in the second quarter of 2026. Therefore, the targeted timeline was met.
Community Health has consistently pursued a strategy of divesting healthcare facilities over the years, which do not fall under any of its strategically beneficial service areas, are less closely aligned with its business strategy or grapple with a low level of operating profit.
Impressive Divestiture Spree So Far
The divestiture spree that Community Health has embarked on so far in 2026 is quite active. Before the recent divestiture, in March 2026, CYH inked an agreement to divest four Arkansas-based hospitals to Freeman Health System. These are named Northwest Medical Center – Bentonville, Northwest Medical Center – Springdale, Northwest Medical Center – Willow Creek Women’s Hospital and Siloam Springs Regional Hospital. The divestiture of the four facilities is likely to be completed in the second quarter of 2026.
This February, CYH’s subsidiaries completed the sale of its 80% ownership stake in joint ventures operating Tennova Healthcare–Clarksville and related ancillary businesses to Vanderbilt University Medical Center for $623 million. In the same month itself, Community Health divested three Pennsylvania-based hospitals, Regional Hospital of Scranton, Moses Taylor Hospital and Wilkes-Barre General Hospital to Tenor Health Foundation.
In 2025, CYH sold four hospitals and a majority stake in three hospitals, thereby receiving more than $1 billion in total net proceeds. In 2023 and 2024, CYH sold eight and two hospitals, respectively.
Benefits of Such Divestitures to CYH
Divesting non-core assets enables Community Health to unlock capital that can be redirected toward higher-return business operations. Proceeds from these transactions are likely to be used to reduce debt and support capital expenditures. Debt repayment brings down the interest expenses of a company and therefore, provides an impetus to its bottom line.
As of Dec. 31, 2025, long-term debt of CYH declined 9.2% from the 2024-end level. While divestiture proceeds help manage debt obligations, the company continues to fund growth initiatives through its cash reserves and operating cash flows. Cash and cash equivalents increased sevenfold from the 2024-end level. Net cash provided by operating activities advanced 13.1% year over year in 2025.
CYH’s Share Price Performance & Zacks Rank
Shares of Community Health have gained 17.4% in the past year compared with the industry’s 12.1% growth. CYH currently carries a Zacks Rank #2 (Buy).
Enovis’ earnings surpassed the Zacks Consensus Estimate in each of the last four quarters, the average beat being 11.36%. The Zacks Consensus Estimate for ENOV’s 2026 earnings and revenues suggests an improvement of 4.2% and 4.3% from the respective year-ago reported figures.
The consensus estimate for Enovis’ 2026 earnings has moved 5.5% north in the past 60 days. Shares of ENOV have declined 32% in the past year.
Globus Medical’s earnings outpaced the Zacks Consensus Estimate in three of the trailing four quarters and missed the mark once, the average surprise being 18.79%. The consensus estimate for GMED’s 2026 earnings and revenues suggests an improvement of 12.1% and 8.7% from the respective year-ago reported figures.
The consensus estimate for Globus Medical’s 2026 earnings has moved 4.2% north in the past 30 days. Shares of GMED have gained 22.8% in the past year.
BrightSpring Health’s earnings outpaced the Zacks Consensus Estimate in three of the trailing four quarters and missed the mark once, the average surprise being 40.37%. The Zacks Consensus Estimate for BTSG’s 2026 earnings and revenues suggests an improvement of 61% and 14.8% from the respective year-ago reported figures.
The consensus estimate for BrightSpring Health’s 2026 earnings has moved 4.5% north in the past 30 days. Shares of BTSG have gained 141.4% in the past year.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Shutterstock
CYH Sustains Its Divestiture Spree Through Alabama Facility Sale
Key Takeaways
Community Health Systems, Inc. (CYH - Free Report) recently completed the sale of Alabama-based Crestwood Medical Center to Huntsville Hospital Health System for $459 million, prior to certain transaction-related costs. A subsidiary of the company sold all of the assets of Crestwood Medical Center, including its affiliated outpatient facilities and physician practices.
The agreement to sell the 180-bed facility was inked this January and was likely to be completed in the second quarter of 2026. Therefore, the targeted timeline was met.
Community Health has consistently pursued a strategy of divesting healthcare facilities over the years, which do not fall under any of its strategically beneficial service areas, are less closely aligned with its business strategy or grapple with a low level of operating profit.
Impressive Divestiture Spree So Far
The divestiture spree that Community Health has embarked on so far in 2026 is quite active. Before the recent divestiture, in March 2026, CYH inked an agreement to divest four Arkansas-based hospitals to Freeman Health System. These are named Northwest Medical Center – Bentonville, Northwest Medical Center – Springdale, Northwest Medical Center – Willow Creek Women’s Hospital and Siloam Springs Regional Hospital. The divestiture of the four facilities is likely to be completed in the second quarter of 2026.
This February, CYH’s subsidiaries completed the sale of its 80% ownership stake in joint ventures operating Tennova Healthcare–Clarksville and related ancillary businesses to Vanderbilt University Medical Center for $623 million. In the same month itself, Community Health divested three Pennsylvania-based hospitals, Regional Hospital of Scranton, Moses Taylor Hospital and Wilkes-Barre General Hospital to Tenor Health Foundation.
In 2025, CYH sold four hospitals and a majority stake in three hospitals, thereby receiving more than $1 billion in total net proceeds. In 2023 and 2024, CYH sold eight and two hospitals, respectively.
Benefits of Such Divestitures to CYH
Divesting non-core assets enables Community Health to unlock capital that can be redirected toward higher-return business operations. Proceeds from these transactions are likely to be used to reduce debt and support capital expenditures. Debt repayment brings down the interest expenses of a company and therefore, provides an impetus to its bottom line.
As of Dec. 31, 2025, long-term debt of CYH declined 9.2% from the 2024-end level. While divestiture proceeds help manage debt obligations, the company continues to fund growth initiatives through its cash reserves and operating cash flows. Cash and cash equivalents increased sevenfold from the 2024-end level. Net cash provided by operating activities advanced 13.1% year over year in 2025.
CYH’s Share Price Performance & Zacks Rank
Shares of Community Health have gained 17.4% in the past year compared with the industry’s 12.1% growth. CYH currently carries a Zacks Rank #2 (Buy).
Image Source: Zacks Investment Research
Other Stocks to Consider
Some other top-ranked stocks from the Medical space Enovis Corporation (ENOV - Free Report) , Globus Medical, Inc. (GMED - Free Report) and BrightSpring Health Services, Inc. (BTSG - Free Report) , each currently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Enovis’ earnings surpassed the Zacks Consensus Estimate in each of the last four quarters, the average beat being 11.36%. The Zacks Consensus Estimate for ENOV’s 2026 earnings and revenues suggests an improvement of 4.2% and 4.3% from the respective year-ago reported figures.
The consensus estimate for Enovis’ 2026 earnings has moved 5.5% north in the past 60 days. Shares of ENOV have declined 32% in the past year.
Globus Medical’s earnings outpaced the Zacks Consensus Estimate in three of the trailing four quarters and missed the mark once, the average surprise being 18.79%. The consensus estimate for GMED’s 2026 earnings and revenues suggests an improvement of 12.1% and 8.7% from the respective year-ago reported figures.
The consensus estimate for Globus Medical’s 2026 earnings has moved 4.2% north in the past 30 days. Shares of GMED have gained 22.8% in the past year.
BrightSpring Health’s earnings outpaced the Zacks Consensus Estimate in three of the trailing four quarters and missed the mark once, the average surprise being 40.37%. The Zacks Consensus Estimate for BTSG’s 2026 earnings and revenues suggests an improvement of 61% and 14.8% from the respective year-ago reported figures.
The consensus estimate for BrightSpring Health’s 2026 earnings has moved 4.5% north in the past 30 days. Shares of BTSG have gained 141.4% in the past year.